Neuromonics Clinical Summary Details Results of Effective
For sufferers of tinnitus, the condition described as ringing in the ears
when no external sounds are present, treatment and relief have been elusive
and inconsistent. Now, Neuromonics, Inc., has issued a comprehensive
clinical summary of results to help tinnitus sufferers and providers
understand that they can obtain effective treatment.
Neuromonics manufactures and distributes the only FDA-cleared, patented
and clinically proven medical device designed for long-term significant
relief of tinnitus. Clinically administered and monitored, the Neuromonics
Tinnitus Treatment uses the non-invasive device, customized to each
patient's individual audiological profile, to deliver a neural stimulus that
targets the brain's auditory pathways.
The clinical summary, in Word format, is available at Neuromonics'
website, or by requesting a copy by e-mailing
rita.walbert(at)neuromonics(dot)com. The summary includes detailed results
of Neuromonics Tinnitus Treatment's clinical efficacy as presented in papers
appearing in peer-reviewed medical journals. In addition, the summary
outlines nine additional studies that researchers have presented at medical
meetings throughout the United States and Europe. Each provides additional
evidence of clinical efficacy.
"The body of clinical data that Neuromonics has compiled is unmatched by
any other tinnitus treatment provider," says Duane Knight, chief operating
and financial officer with Neuromonics. "The results not only speak to the
long-term efficacy of the treatment in a variety of patient groups, but also
demonstrate that the Neuromonics Tinnitus Treatment repeatedly achieves
clinically significant reductions in tinnitus disturbance and awareness for
The summary provides detail on three clinical trials involving 555
patients who demonstrated a consistent clinical benefit that persisted to 12
months in suitable patients, according to Knight. The peer-reviewed journals
and papers in the summary include:
* Ear Nose & Throat Journal, 2008; 87:330-9. "Treatment of tinnitus with
a customized acoustic neural stimulus: A controlled clinical study"
* Ear and Hearing, 2007; 28:242-59. "The Neuromonics Tinnitus Treatment:
third clinical trial"
* Annals of Otology, Rhinology, and Laryngology, 2008; 117:791-9.
"Treatment of tinnitus with a customized, dynamic acoustic neural stimulus:
clinical outcomes in general private practice"
* Trends in Amplification, 2008; 12:210-22. "Treatment of tinnitus with a
customized, dynamic acoustic neural stimulus: underlying principles and
Neuromonics, Inc. (http://www.neuromonics.com)
Based in Bethlehem, Pa., Neuromonics, Inc., manufactures and distributes
the FDA-cleared, patented and clinically proven medical device designed for
long-term significant relief of tinnitus. With research and development
beginning in the early 1990s, the Neuromonics Tinnitus Treatment has helped
thousands of tinnitus sufferers improve their quality of life and overcome
the daily life challenges associated with tinnitus. The treatment has been
featured on national news media including "The Doctors" and CNN.
Source: Neuromonics, Inc